Mechanical Processing of SVF-Enriched Microfat for Reconstruction of Traumatic Soft Tissue Defects.
Shah NG., Qi B., Zhang D., Zhou M., Yu L.
Cohort Study, published in J Vis Exp (2026) — summary generated from the PubMed abstract.
Early human evidence such as case series or small samples is exploring possible benefits.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Cohort Study
- Journal
- J Vis Exp (2026)
- Country
- United States
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 41801804
- DOI
- 10.3791/69984
Abstract (original English)
Traumatic soft tissue defects pose significant challenges for reconstruction due to tissue loss, impaired vascularity, and difficulties achieving durable coverage. Adipose tissue offers a practical autologous tissue source, and mechanically processed stromal vascular fraction (SVF)-enriched microfat can be prepared intraoperatively without enzymatic digestion. This study presents a standardized clinical protocol for harvesting autologous adipose tissue and processing it into SVF-enriched microfat for injection into cavity-type traumatic soft tissue defects. Fat is harvested manually from the thigh or abdomen under low negative pressure, mechanically fragmented by cutting and syringe-to-syringe emulsification, filtered to achieve uniform microfat consistency, and centrifuged to isolate the SVF-containing fraction. The processed microfat is injected throughout the wound cavity in a multilayered pattern. Postoperative assessment includes serial clinical evaluation, photographic documentation, and measurement of wound-area reduction until epithelialization. In a small cohort, the method was associated with progressive wound contraction and complete epithelialization within approximately 4-8 weeks, with no major complications. Although cellular composition and viability were not quantified, the technique provided a feasible intraoperative approach suitable for settings without acces
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
Evidence level
Early human evidence such as case series or small samples is exploring possible benefits.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.